Eli Lilly Raises 2026 Revenue Outlook to $91 Billion to $92 Billion

Image: TokenPost
Third-quarter revenue rose 39% to $24.397 billion, led by Mounjaro and Zepbound sales.
Read the full story on TokenPostBeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.







